Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | +5.20% | +11.91% | +12.88% |
04/04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
29/02 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on VYNE Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering VYNE Therapeutics Inc.
Cantor Fitzgerald | |
HC Wainwright | |
Northland Securities |
EPS Revisions
- Stock Market
- Equities
- VYNE Stock
- Consensus VYNE Therapeutics Inc.